Abiopharma

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001213900-26-053140 <b>Size:</b> 2 MB

Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026 and Provides Update on Recent Business Progress

(30% Negative) ACORN ENERGY, INC. (ACFN) Reports Q2 2026 Financial Results

(70% Positive) ORAGENICS INC (OGEN) Announces Business Combination

(30% Negative) SILENCE THERAPEUTICS PLC (SLN) Reports Q2 2026 Financial Results

Ocean Power Technologies Advances Offshore Charging and Autonomous Operations for Maritime Drones

Regency Centers Declares Quarterly Dividends

Inuvo to Host First Quarter 2026 Financial Results Conference Call on Thursday, May 14th at 4:15 P.M. ET

Starstream Entertainment Inc. Completes Name Change to CityWalk e-Bike Inc: A Company Focused on Electric & Hydrogen e-Bike Rental & Manufacturing in China: Begins Trading Under New Symbol OTCID: CWLK

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001918704-26-012441 <b>Size:</b> 327 KB

(70% Positive) VIASAT INC (VSAT) Announces Business Combination

(30% Negative) SUBURBAN PROPANE PARTNERS LP (SPH) Reports Q2 2026 Financial Results

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001918704-26-012440 <b>Size:</b> 724 KB

Theriva™ Biologics presenta los aspectos operativos más destacados y los resultados financieros del primer trimestre de 2026

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001918704-26-012439 <b>Size:</b> 704 KB